Phase separation of FSP1 promotes ferroptosis

Ferroptosis is evolving as a highly promising approach to combat difficult-to-treat tumour entities including therapy-refractory and dedifferentiating cancers(1–3). Recently, ferroptosis suppressor protein-1 (FSP1), along with extramitochondrial ubiquinone or exogenous vitamin K and NAD(P)H/H(+) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Toshitaka, Hipp, Clara, Santos Dias Mourão, André, Borggräfe, Jan, Aldrovandi, Maceler, Henkelmann, Bernhard, Wanninger, Jonas, Mishima, Eikan, Lytton, Elena, Emler, David, Proneth, Bettina, Sattler, Michael, Conrad, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338336/
https://www.ncbi.nlm.nih.gov/pubmed/37380771
http://dx.doi.org/10.1038/s41586-023-06255-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338336/
https://www.ncbi.nlm.nih.gov/pubmed/37380771
http://dx.doi.org/10.1038/s41586-023-06255-6

Ejemplares similares